• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Decibel Therapeutics Inc.

    2/14/22 12:30:53 PM ET
    $DBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DBTX alert in real time by email
    SC 13G 1 d262117dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    Schedule 13G

    Under the Securities Exchange Act of 1934

    (Amendment No.     )*

     

     

    Decibel Therapeutics, Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

    24343R106

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on following pages)

     

     

     


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2016, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      321,978 (1)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

        321,978 (2)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      321,978

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (1)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P.

    (2) 

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 2 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2016 GP, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      321,978 (1)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      321,978 (2)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      321,978

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (1)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P.

    (2) 

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 3 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2016 GP, L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      321,978 (1)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      321,978 (2)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      321,978

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      OO

     

    (1)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P.

    (2) 

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 4 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2017, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      494,649 (4)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      494,649 (5)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      494,649

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.98% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (4)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P.

    (5)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 5 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2017 GP, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      494,649 (4)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      494,649 (5)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      494,649

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.98% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (4)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P.

    (5)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 6 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2017 GP, L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      494,649 (4)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      494,649 (5)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      494,649

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.98% (3)

    12    

      TYPE OF REPORTING PERSON

     

      OO

     

    (4)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P.

    (5)

    Consists of 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 7 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2019, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      819,631 (6)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      819,631 (7)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      819,631

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      3.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (6)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (7)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 8 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2019 GP, L.P.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      819,631 (6)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      819,631 (7)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      819,631

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      3.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      PN

     

    (6)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (7)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 9 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      GV 2019 GP, L.L.C.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      819,631 (6)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      819,631 (7)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      819,631

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      3.29% (3)

    12    

      TYPE OF REPORTING PERSON

     

      OO

     

    (6)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (7)

    Consists of 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 10 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      Alphabet Holdings LLC

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      1,636,258 (8)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      1,636,258 (9)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,636,258

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      6.57% (3)

    12    

      TYPE OF REPORTING PERSON

     

      OO

     

    (8)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (9)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 11 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      XXVI Holdings Inc.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      1,636,258 (8)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      1,636,258 (9)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,636,258

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      6.57% (3)

    12    

      TYPE OF REPORTING PERSON

     

      CO

     

    (8)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (9)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 12 of 19


    CUSIP No. 24343R106    13G   

     

      1    

      NAME OF REPORTING PERSONS

     

      Alphabet Inc.

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5     

      SOLE VOTING POWER

     

      1,636,258 (8)

      6     

      SHARED VOTING POWER

     

      See response to row 5.

      7     

      SOLE DISPOSITIVE POWER

     

      1,636,258 (9)

      8     

      SHARED DISPOSITIVE POWER

     

      See response to row 7.

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,636,258

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      6.57% (3)

    12    

      TYPE OF REPORTING PERSON

     

      CO, HC

     

    (8)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote the shares held directly by GV 2019, L.P.

    (9)

    Consists of 321,978 shares of the Issuer’s Common Stock held directly by GV 2016, L.P., 494,649 shares of the Issuer’s Common Stock held directly by GV 2017, L.P., and 819,631 shares of the Issuer’s Common Stock held directly by GV 2019, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2016, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2017, L.P. GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to dispose of the shares held directly by GV 2019, L.P.

    (3)

    Based on 24,923,363 shares of the Issuer’s Common Stock outstanding as of November 1, 2021 as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.

     

    Page 13 of 19


    ITEM 1(A).

    NAME OF ISSUER

    Decibel Therapeutics, Inc.

     

    ITEM 1(B).

    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

    1325 Boylston Street, Suite 500

    Boston, MA 02215

     

    ITEM 2(A).

    NAME OF PERSONS FILING:

    This statement is filed by the following entities, collectively referred to as the “Reporting Persons”:

     

      •

    GV 2016, L.P., a Delaware limited partnership

     

      •

    GV 2016 GP, L.P., a Delaware limited partnership

     

      •

    GV 2016 GP, L.L.C., a Delaware limited liability company

     

      •

    GV 2017, L.P., a Delaware limited partnership

     

      •

    GV 2017 GP, L.P., a Delaware limited partnership

     

      •

    GV 2017 GP, L.L.C., a Delaware limited liability company

     

      •

    GV 2019, L.P., a Delaware limited partnership

     

      •

    GV 2019 GP, L.P., a Delaware limited partnership

     

      •

    GV 2019 GP, L.L.C., a Delaware limited liability company

     

      •

    Alphabet Holdings LLC, a Delaware limited liability company

     

      •

    XXVI Holdings Inc., a Delaware corporation, and

     

      •

    Alphabet Inc., a Delaware corporation

    Each of GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may be deemed to have sole power to vote or sole power to dispose of the securities owned directly by GV 2016, L.P.

    Each of GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may be deemed to have sole power to vote or sole power to dispose of the securities owned directly by GV 2017, L.P.

    Each of GV 2019 GP, L.P. (the general partner of GV 2019, L.P.), GV 2019 GP, L.L.C. (the general partner of GV 2019 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2019 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may be deemed to have sole power to vote or sole power to dispose of the securities owned directly by GV 2019, L.P.

     

    ITEM 2(B).

    ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:

    The address of the principal business office for each of the Reporting Persons is:

    1600 Amphitheatre Parkway

    Mountain View, CA 94043

     

    Page 14 of 19


    ITEM 2(C).

    CITIZENSHIP:

    GV 2016, L.P. is a Delaware limited partnership, GV 2016 GP, L.P. is a Delaware limited partnership, GV 2016 GP, L.L.C. is a Delaware limited liability company, GV 2017, L.P. is a Delaware limited partnership, GV 2017 GP, L.P. is a Delaware limited partnership, GV 2017 GP, L.L.C. is a Delaware limited liability company, GV 2019, L.P. is a Delaware limited partnership, GV 2019 GP, L.P. is a Delaware limited partnership, GV 2019 GP, L.L.C. is a Delaware limited liability company, Alphabet Holdings LLC is a Delaware limited liability company, XXVI Holdings Inc. is a Delaware corporation, and Alphabet Inc. is a Delaware corporation.

     

    ITEM 2(D)/(E).

    TITLE OF CLASS OF SECURITIES AND CUSIP NUMBER:

    Common Stock, par value $0.001 per share

    CUSIP # 24343R106

     

    ITEM 3.

    Not Applicable.

     

    ITEM 4.

    OWNERSHIP:

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a)

    Amount beneficially owned:

    See Row 9 of cover page for each Reporting Person.

     

      (b)

    Percent of Class:

    See Row 11 of cover page for each Reporting Person.

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote:

    See Row 5 of cover page for each Reporting Person.

     

      (ii)

    Shared power to vote or to direct the vote:

    See Row 6 of cover page for each Reporting Person.

     

      (iii)

    Sole power to dispose or to direct the disposition of:

    See Row 7 of cover page for each Reporting Person.

     

      (iv)

    Shared power to dispose or to direct the disposition of:

    See Row 8 of cover page for each Reporting Person.

     

    ITEM 5.

    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

    Not Applicable.

     

    Page 15 of 19


    ITEM 6.

    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

    Under certain circumstances set forth in the limited partnership agreement of GV 2016, L.P., the limited partnership agreement of GV 2017, L.P., the limited partnership agreement of GV 2019, L.P., the limited partnership agreement of GV 2016 GP, L.P., the limited partnership agreement of GV 2017 GP, L.P., the limited partnership agreement of GV 2019 GP, L.P., the limited liability company agreement of GV 2016 GP, L.L.C., the limited liability company agreement of GV 2017 GP, L.L.C., and the limited liability company agreement of GV 2019 GP, L.L.C., the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a general partner, limited partner, or member.

     

    ITEM 7.

    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

    Not Applicable.

     

    ITEM 8.

    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

    Not Applicable.

     

    ITEM 9.

    NOTICE OF DISSOLUTION OF GROUP:

    Not Applicable.

     

    ITEM 10.

    CERTIFICATION:

    Not Applicable.

     

    Page 16 of 19


    SIGNATURES

    After reasonable inquiry and to the best of her or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: February 11, 2022

     

    GV 2016, L.P.
    By: GV 2016 GP, L.P., its General Partner
    By: GV 2016 GP, L.L.C., its General Partner
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2016 GP, L.P.
    By: GV 2016 GP, L.L.C., its General Partner
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2016 GP, L.L.C.
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2017, L.P.
    By: GV 2017 GP, L.P., its General Partner
    By: GV 2017 GP, L.L.C., its General Partner
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2017 GP, L.P.
    By: GV 2017 GP, L.L.C., its General Partner
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2017 GP, L.L.C
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2019, L.P.
    By: GV 2019 GP, L.P., its General Partner
    By: GV 2019 GP, L.L.C., its General Partner
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2019 GP, L.P.
    By: GV 2019 GP, L.L.C., its General Partner

     

    Page 17 of 19


    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    GV 2019 GP, L.L.C.
    By: Alphabet Holdings LLC, its Sole Member
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    Alphabet Holdings LLC
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Secretary
    XXVI Holdings Inc.
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Assistant Secretary
    Alphabet Inc.
    By:  

    /s/ Kathryn W. Hall

    Name: Kathryn W. Hall
    Title: Assistant Secretary

     

    Page 18 of 19


    EXHIBIT INDEX

     

    Exhibit

       Found on
    Sequentially
    Numbered Page
     

    Exhibit A: Agreement of Joint Filing

         20  

     

    Page 19 of 19

    Get the next $DBTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DBTX

    DatePrice TargetRatingAnalyst
    3/15/2023$7.00 → $2.00Outperform → Market Perform
    SVB Securities
    12/2/2021$25.00Buy
    JonesTrading
    11/15/2021$23.00Buy
    HC Wainwright & Co.
    11/10/2021$15.00 → $14.00Outperform
    SVB Leerink
    10/22/2021$21.00Outperform
    Robert W. Baird
    10/22/2021$21.00Outperform
    Baird
    More analyst ratings

    $DBTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Trask Anna returned 106,864 shares to the company, closing all direct ownership in the company

      4 - Decibel Therapeutics, Inc. (0001656536) (Issuer)

      9/25/23 4:35:59 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Carson William H. returned 5,000 shares to the company, closing all direct ownership in the company

      4 - Decibel Therapeutics, Inc. (0001656536) (Issuer)

      9/25/23 4:32:58 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Lee John Jui-Jen returned 147,144 shares to the company, closing all direct ownership in the company

      4 - Decibel Therapeutics, Inc. (0001656536) (Issuer)

      9/25/23 4:30:31 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DBTX
    SEC Filings

    See more
    • SEC Form 15-12G filed by Decibel Therapeutics Inc.

      15-12G - Decibel Therapeutics, Inc. (0001656536) (Filer)

      10/10/23 4:56:54 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Decibel Therapeutics Inc.

      EFFECT - Decibel Therapeutics, Inc. (0001656536) (Filer)

      10/10/23 12:15:13 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form S-8 POS filed by Decibel Therapeutics Inc.

      S-8 POS - Decibel Therapeutics, Inc. (0001656536) (Filer)

      9/25/23 9:09:56 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DBTX
    Leadership Updates

    Live Leadership Updates

    See more
    • Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

      - Initiated CHORD™, a global Phase 1/2 dose escalation clinical trial of lead gene therapy product candidate, DB-OTO - - Announced approval from the U.K. MHRA and Spanish AEMPS for CTAs for CHORD to expand the Phase 1/2 clinical trial to the U.K. and Spain in patients two years of age and younger - - Initiated manufacturing activities to support IND-enabling studies for our AAV.103 product candidate designed to restore hearing in individuals with mutations in the GJB2 gene - BOSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing

      5/15/23 7:45:00 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors

      BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of Matthew Kapusta to its Board of Directors. "We are pleased to welcome Matt to the Decibel Board. He is an accomplished life sciences executive who has played a key role in advancing gene therapy products from the laboratory to patients in need," said Laurence Reid, Ph.D., Chief Executive Officer at Decibel. "Matt's appointment to the Board provides us with a critical strategic perspective, as we continue to build Decibel and lead

      3/21/23 7:00:34 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

      - Received clearance from US FDA for IND and from UK MHRA for CTA to initiate CHORD™, a global Phase 1/2 dose escalation clinical trial of DB-OTO in pediatric patients - - Plan to initiate the CHORD™ trial in the First Half of 2023 - - Presented key non-clinical data at the 46th Annual ARO MidWinter Meeting supporting compelling safety profile of DB-OTO and preclinical data supporting selection of AAV.103 product candidate - BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial result

      3/14/23 4:05:00 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DBTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Decibel Therapeutics downgraded by SVB Securities with a new price target

      SVB Securities downgraded Decibel Therapeutics from Outperform to Market Perform and set a new price target of $2.00 from $7.00 previously

      3/15/23 7:30:18 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • JonesTrading initiated coverage on Decibel Therapeutics with a new price target

      JonesTrading initiated coverage of Decibel Therapeutics with a rating of Buy and set a new price target of $25.00

      12/2/21 8:42:59 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. initiated coverage on Decibel Therapeutics with a new price target

      HC Wainwright & Co. initiated coverage of Decibel Therapeutics with a rating of Buy and set a new price target of $23.00

      11/15/21 6:07:44 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DBTX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifshitz Law PLLC Announces Investigations of WMC, MITT, DBTX, and CTG

      NEW YORK, Aug. 12, 2023 (GLOBE NEWSWIRE) -- Western Asset Mortgage Capital Corporation (NYSE:WMC) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of WMC to AG Mortgage Investment Trust, Inc. Under the terms of the proposed merger, WMC shareholders will receive 1.5 shares of AG Mortgage Investment Trust, Inc. for each share of WMC common stocked owned and a cash payment from Angelo Gordon equal to approximately 9.99% of the aggregate per share merger consideration (not to exceed $7 million in total). If you are a WMC investor, and would like additional information about our investigation, please complete the Information R

      8/12/23 8:17:00 PM ET
      $CTG
      $DBTX
      $MITT
      $WMC
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

      - Activated CHORDTM clinical trial sites in U.S., U.K. and Spain and commenced patient screening activities; anticipate dosing first patient in the Phase 1/2 clinical trial in the second half of 2023 - - Received FDA Breakthrough Therapy Designation for DB-020 for protection against hearing loss associated with cisplatin chemotherapy - - Announced on August 9 definitive agreement for Regeneron Pharmaceuticals to acquire Decibel - BOSTON, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financi

      8/11/23 7:45:00 AM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs

      Proposed acquisition builds on existing collaboration between Decibel and Regeneron, will accelerate and further resource key gene therapy programs for hearing loss Decibel's lead investigational gene therapy DB-OTO, designed to provide hearing to people with otoferlin-related hearing loss, is in its first clinical trial TARRYTOWN, N.Y. and BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Decibel Therapeutics, Inc. (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced a definitive agreement for the acquisition of

      8/9/23 7:30:53 AM ET
      $DBTX
      $REGN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DBTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Decibel Therapeutics Inc. (Amendment)

      SC 13G/A - Decibel Therapeutics, Inc. (0001656536) (Subject)

      2/14/24 4:55:24 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by Decibel Therapeutics Inc. (Amendment)

      SC 13D/A - Decibel Therapeutics, Inc. (0001656536) (Subject)

      9/27/23 4:05:18 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D filed by Decibel Therapeutics Inc.

      SC 13D - Decibel Therapeutics, Inc. (0001656536) (Subject)

      8/18/23 5:16:09 PM ET
      $DBTX
      Biotechnology: Pharmaceutical Preparations
      Health Care